Cochlear Limited (COH.AX)
AUD 275.02
(-0.17%)
AUD 275.02
(-0.17%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 2.25 Billion AUD | 15.47% |
| 2023 | 1.95 Billion AUD | 19.17% |
| 2022 | 1.64 Billion AUD | 9.9% |
| 2021 | 1.49 Billion AUD | 10.43% |
| 2020 | 1.35 Billion AUD | -5.21% |
| 2019 | 1.42 Billion AUD | 4.62% |
| 2018 | 1.36 Billion AUD | 8.77% |
| 2017 | 1.25 Billion AUD | 10.9% |
| 2016 | 1.13 Billion AUD | 22.14% |
| 2015 | 925.63 Million AUD | 14.99% |
| 2014 | 804.93 Million AUD | 6.94% |
| 2013 | 752.72 Million AUD | -3.37% |
| 2012 | 778.99 Million AUD | -3.79% |
| 2011 | 809.64 Million AUD | 10.19% |
| 2010 | 734.8 Million AUD | 5.77% |
| 2009 | 694.69 Million AUD | 15.45% |
| 2008 | 601.72 Million AUD | 7.56% |
| 2007 | 559.41 Million AUD | 23.69% |
| 2006 | 452.26 Million AUD | 31.15% |
| 2005 | 344.85 Million AUD | 21.95% |
| 2004 | 282.77 Million AUD | -2.01% |
| 2003 | 288.57 Million AUD | 13.18% |
| 2002 | 254.98 Million AUD | 15.84% |
| 2001 | 220.11 Million AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | -100.0% |
| 1997 | 72.92 Million AUD | 0.9% |
| 1996 | 72.27 Million AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 2.25 Billion AUD | 15.47% |
| 2024 Q4 | 1.14 Billion AUD | 0.0% |
| 2024 Q2 | 1.11 Billion AUD | 0.0% |
| 2023 Q2 | 892.6 Million AUD | 0.0% |
| 2023 FY | 1.95 Billion AUD | 19.17% |
| 2023 Q4 | 1.06 Billion AUD | 0.0% |
| 2022 Q4 | 825.8 Million AUD | 0.0% |
| 2022 Q2 | 815.3 Million AUD | 0.0% |
| 2022 FY | 1.64 Billion AUD | 9.9% |
| 2021 Q2 | 742.8 Million AUD | 0.0% |
| 2021 FY | 1.49 Billion AUD | 10.43% |
| 2021 Q4 | 750.5 Million AUD | 0.0% |
| 2020 Q2 | 777.6 Million AUD | 0.0% |
| 2020 FY | 1.35 Billion AUD | -5.21% |
| 2020 Q4 | 574.7 Million AUD | 0.0% |
| 2019 Q2 | 703.8 Million AUD | 0.0% |
| 2019 Q4 | 722.9 Million AUD | 0.0% |
| 2019 FY | 1.42 Billion AUD | 4.62% |
| 2018 Q4 | 714.1 Million AUD | 0.0% |
| 2018 FY | 1.36 Billion AUD | 8.77% |
| 2018 Q2 | 649.6 Million AUD | 0.0% |
| 2017 Q4 | 644.6 Million AUD | 0.0% |
| 2017 FY | 1.25 Billion AUD | 10.9% |
| 2017 Q2 | 609.2 Million AUD | 0.0% |
| 2016 FY | 1.13 Billion AUD | 22.14% |
| 2016 Q4 | 572.46 Million AUD | 0.0% |
| 2016 Q2 | 558.08 Million AUD | 0.0% |
| 2015 Q4 | 487.28 Million AUD | 0.0% |
| 2015 Q2 | 438.34 Million AUD | 0.0% |
| 2015 FY | 925.63 Million AUD | 14.99% |
| 2014 Q2 | 371.06 Million AUD | 0.0% |
| 2014 FY | 804.93 Million AUD | 6.94% |
| 2014 Q4 | 433.87 Million AUD | 0.0% |
| 2013 Q4 | 361.02 Million AUD | 91.85% |
| 2013 Q3 | 188.18 Million AUD | 0.0% |
| 2013 Q2 | 188.18 Million AUD | -3.37% |
| 2013 Q1 | 194.74 Million AUD | 0.0% |
| 2013 FY | 752.72 Million AUD | -3.37% |
| 2012 Q4 | - AUD | -100.0% |
| 2012 Q2 | 194.74 Million AUD | -3.79% |
| 2012 Q1 | 202.41 Million AUD | 0.0% |
| 2012 FY | 778.99 Million AUD | -3.79% |
| 2012 Q3 | 194.74 Million AUD | 0.0% |
| 2011 Q1 | 183.7 Million AUD | 0.0% |
| 2011 Q2 | 202.41 Million AUD | 10.19% |
| 2011 Q3 | 202.41 Million AUD | 0.0% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 FY | 809.64 Million AUD | 10.19% |
| 2010 FY | 734.8 Million AUD | 5.77% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 Q3 | 183.7 Million AUD | 0.0% |
| 2010 Q2 | 183.7 Million AUD | 5.77% |
| 2010 Q1 | 173.67 Million AUD | 0.0% |
| 2009 Q2 | 173.67 Million AUD | 15.45% |
| 2009 FY | 694.69 Million AUD | 15.45% |
| 2009 Q3 | 173.67 Million AUD | 0.0% |
| 2009 Q1 | 150.43 Million AUD | 0.0% |
| 2009 Q4 | - AUD | -100.0% |
| 2008 Q1 | 139.85 Million AUD | 0.0% |
| 2008 Q2 | 150.43 Million AUD | 7.56% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 FY | 601.72 Million AUD | 7.56% |
| 2008 Q3 | 150.43 Million AUD | 0.0% |
| 2007 FY | 559.41 Million AUD | 23.69% |
| 2007 Q3 | 139.85 Million AUD | 0.0% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 Q2 | 139.85 Million AUD | 23.69% |
| 2007 Q1 | 113.06 Million AUD | 0.0% |
| 2006 FY | 452.26 Million AUD | 31.15% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 Q3 | 113.06 Million AUD | 0.0% |
| 2006 Q2 | 113.06 Million AUD | 31.15% |
| 2006 Q1 | 86.21 Million AUD | 0.0% |
| 2005 Q1 | 70.69 Million AUD | 0.0% |
| 2005 Q2 | 86.21 Million AUD | 21.95% |
| 2005 Q3 | 86.21 Million AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2005 FY | 344.85 Million AUD | 21.95% |
| 2004 Q1 | 72.14 Million AUD | 0.0% |
| 2004 FY | 282.77 Million AUD | -2.01% |
| 2004 Q2 | 70.69 Million AUD | -2.01% |
| 2004 Q3 | 70.69 Million AUD | 0.0% |
| 2004 Q4 | - AUD | -100.0% |
| 2003 FY | 288.57 Million AUD | 13.18% |
| 2003 Q2 | 72.14 Million AUD | 13.18% |
| 2003 Q1 | 63.74 Million AUD | 0.0% |
| 2003 Q3 | 72.14 Million AUD | 0.0% |
| 2003 Q4 | - AUD | -100.0% |
| 2002 FY | 254.98 Million AUD | 15.84% |
| 2002 Q2 | 63.74 Million AUD | 15.84% |
| 2002 Q3 | 63.74 Million AUD | 0.0% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 Q1 | 55.02 Million AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 Q3 | 55.02 Million AUD | 0.0% |
| 2001 Q4 | - AUD | -100.0% |
| 2001 FY | 220.11 Million AUD | 0.0% |
| 2001 Q2 | 55.02 Million AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 FY | - AUD | -100.0% |
| 1998 Q1 | 18.23 Million AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | -100.0% |
| 1997 Q4 | - AUD | -100.0% |
| 1997 Q1 | 18.06 Million AUD | 0.0% |
| 1997 Q2 | 18.23 Million AUD | 0.9% |
| 1997 Q3 | 18.23 Million AUD | 0.0% |
| 1997 FY | 72.92 Million AUD | 0.9% |
| 1996 Q3 | 18.06 Million AUD | 0.0% |
| 1996 Q2 | 18.06 Million AUD | 0.0% |
| 1996 Q4 | 18.06 Million AUD | 0.0% |
| 1996 FY | 72.27 Million AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -60050.4% |
| Adherium Limited | 840.98 Thousand AUD | -268419.421% |
| Aroa Biosurgery Limited | 63.35 Million AUD | -3464.219% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -55159.529% |
| Anteris Technologies Ltd | 4.11 Million AUD | -54829.592% |
| Control Bionics Limited | 5.12 Million AUD | -43946.136% |
| CardieX Limited | 10.9 Million AUD | -20606.724% |
| Compumedics Limited | 49.71 Million AUD | -4441.926% |
| CleanSpace Holdings Limited | 15.72 Million AUD | -14263.586% |
| Cyclopharm Limited | 27.13 Million AUD | -8220.695% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | -20027.988% |
| Nova Eye Medical Limited | 23.32 Million AUD | -9581.458% |
| HeraMED Limited | 402.89 Thousand AUD | -560390.646% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -366748.179% |
| ImpediMed Limited | 10.31 Million AUD | -21783.903% |
| InhaleRx Limited | 1.2 Million AUD | -187450.974% |
| LBT Innovations Limited | 1.25 Million AUD | -179692.994% |
| Micro-X Limited | 15.22 Million AUD | -14735.107% |
| Neurotech International Limited | 1963.00 AUD | -115038106.826% |
| OncoSil Medical Limited | 1.56 Million AUD | -144158.626% |
| PolyNovo Limited | 103.19 Million AUD | -2088.348% |
| Respiri Limited | 456.91 Thousand AUD | -494128.673% |
| SomnoMed Limited | 91.65 Million AUD | -2363.91% |
| Universal Biosensors, Inc. | 6.63 Million AUD | -33945.758% |
| Uscom Limited | 3.72 Million AUD | -60492.807% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | -25946.136% |